Advertisement

Weight reduction drug growth is booming in China. This is why


Thank you for reading this post, don't forget to subscribe!

Allison DeAngelis is the East Coast biotech and enterprise capital reporter at STAT, reporting the place scientific concepts and cash meet. She can be co-host of the weekly biotech podcast, The Readout Loud. You’ll be able to attain Allison on Sign at AllisonDeAngelis.01.

China has one of many lowest charges of weight problems within the developed world. So why has it emerged as one of many prime areas for testing the scores of latest weight reduction medication cropping up each month?

Based on a report from medical analysis group Novotech, China is the second-most-popular nation for weight problems trials in recent times, behind the U.S. and forward of Australia. However simply 6% of Chinese language persons are thought-about overweight, in comparison with 31% of Australians and 40% of People. 

That will make the Chinese language market appear small. However China has almost 1.4 billion residents, and the quantity eligible for weight problems drug trials and coverings is rising. “What’s attention-grabbing is that, though the speed of weight problems in China shouldn’t be that top, in comparison with different nations, I believe inside China itself, [the rate of] obese and weight problems continues to rise,” mentioned Shipra Patel, the worldwide head of endocrinology on the medical analysis agency Parexel. “So, they do symbolize a large marketplace for sufferers with weight problems.”

STAT+ Unique Story

STAT+





This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.

Have already got an account? Log in

View All Plans

To learn the remainder of this story subscribe to STAT+.

Subscribe